Use of antibody drug conjugate

To provide an antitumor drug having an excellent therapeutic effect, which is excellent in terms of antitumor effect and safety. The present invention provides an anti-TROP2 antibody having CDRH1 comprising the amino acid sequence represented by SEQ ID No. 23, CDRH2 comprising the amino acid sequenc...

Full description

Saved in:
Bibliographic Details
Main Authors TAKAHASHI, SHU, YAMAGUCHI, MIKI, HAMADA, HIROFUMI, OKAJIMA, DAISUKE, HASEGAWA, JUN, AGATSUMA, TOSHINORI
Format Patent
LanguageChinese
English
Published 16.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide an antitumor drug having an excellent therapeutic effect, which is excellent in terms of antitumor effect and safety. The present invention provides an anti-TROP2 antibody having CDRH1 comprising the amino acid sequence represented by SEQ ID No. 23, CDRH2 comprising the amino acid sequence represented by SEQ ID No. 24, and CDRH3 comprising the amino acid sequence represented by SEQ ID No. 25 in the heavy chain variable region; and CDRL1 comprising the amino acid sequence represented by SEQ ID No. 26, CDRL2 comprising the amino acid sequence represented by SEQ ID No. 27, and CDRL3 comprising the amino acid sequence represented by SEQ ID No. 28 in the light chain variable region.
Bibliography:Application Number: TW202312127350